Xeris Pharmaceuticals Secures $1,125,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=842c512b-2f84-4c2e-9da5-77048719771a&Preview=1 - Date
9/26/2012 - Company Name
Xeris Pharmaceuticals - Mailing Address
3925 West Braker Lane Third Floor Austin, TX 78759 - Company Description
Xeris is an Austin, Texas-based specialty pharmaceutical company developing patient-friendly injectables for indications in diabetes, epilepsy, and immunology. The company’s disruptive formulation and delivery technologies allow for the subcutaneous delivery of highly concentrated, non-aqueous paste and liquid formulations of all drug classes, including small molecules, peptides, proteins, antibodies, and nucleic-acid-based therapeutics. - Website
http://www.xerispharma.com - Transaction Type
Debt - Transaction Amount
$1,125,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
